ADMA Biologics ADMA Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 61.3%+3.9pp | 57.4%+2.7pp | 54.7%+1.7pp | 53%+0.4pp | 52.6%+1.1pp | |
| Operating margin | 42.1%+4.6pp | 37.5%+3.3pp | 34.2%+1.4pp | 32.8%-0.3pp | 33.1%+0.5pp | |
| Net margin | 32.4%+3.6pp | 28.8%-14.1pp | 42.9%-1.2pp | 44.1%-0.9pp | 45%-1.3pp | |
| Returns | ||||||
| Return on equity | 43.3%+7.7pp | 35.6%-27.6pp | 63.2%-8.1pp | 71.2%-7.2pp | 78.5%-3.2pp | |
| Return on invested capital | 44.8%+6.2pp | 38.6%-16.3pp | 54.9%-17.7pp | 72.6%+1.9pp | 70.7%+4.9pp | |
| Efficiency | ||||||
| Asset turnover | 0.9×0.0× | 0.9×-0.1× | 1×0.0× | 1×-0.1× | 1.1×0.0× | |
| Liquidity | ||||||
| Current ratio | 7×+0.2× | 6.7×-0.4× | 7.1×+1.8× | 5.3×-1.2× | 6.6×+0.6× | |
| Leverage | ||||||
| Debt-to-equity | 0.5×+0.4× | 0.2×0.0× | 0.2×+0.2× | 0×0.0× | 0×-0.2× | |
| Net debt / EBITDA | 0.3×+0.3× | -0×-0.2× | 0.1×+0.6× | -0.5×-0.1× | -0.4×-0.2× | |
| Per Share | ||||||
| Book value per share | $1.63-16.5% | $1.95+10.6% | $1.76+10.0% | $1.60+5.0% | $1.53+6.4% | |
| Valuation | ||||||
| Market capitalization | $2.15B-50.6% | $4.34B+24.1% | $3.5B-17.9% | $4.26B-9.6% | $4.71B+16.3% | |
| Price / earnings | 13×-16.6× | 29.5×+12.8× | 16.7×-3.7× | 20.4×-2.4× | 22.8×+2.3× | |
| Price / sales | 4.2×-4.3× | 8.5×+1.3× | 7.2×-1.8× | 9×-1.3× | 10.3×+0.8× | |
| Price / book | 5.5×-3.6× | 9.1×+1.0× | 8.1×-2.6× | 10.7×-1.9× | 12.6×+1.0× | |
| EV / EBITDA | 9.9×-11.8× | 21.7×+1.6× | 20.1×-5.5× | 25.6×-3.5× | 29.1×+1.6× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are ADMA Biologics's profit margins?
- ADMA Biologics (ADMA) runs a 61.3% gross margin and a 42.1% operating margin, with a 32.4% net margin.
- Where do ADMA Biologics's ratios come from?
- Every ratio is computed from ADMA Biologics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
